Skip to main content

Cardiovascular Safety of Rybelsus® vs. Placebo (PIONEER 6 Study)

This video discusses the trial-design and outcomes of the PIONEER 6 study. PIONEER 6 was a phase 3a, randomized, double-blind, multinational trial that enrolled 3183 adult patients (age ≥50 years) with type 2 diabetes. Eligible patients were at least 50 years of age with established cardiovascular (CV) disease or chronic kidney disease, or patients were at least 60 years of age with at least one CV risk factor.

Play
Pause
Skip
Volume
Chapters
Transcript
References
video_su
Fullscreen

Cardiovascular Safety of Rybelsus® vs. Placebo (PIONEER 6 Study)

Chapters
Transcript
References

Return to overview

Transcripts

Return to overview

References